Molecular Therapy - Nucleic Acids
Volume 13, 7 December 2018, Pages 208-219
Original ArticleHIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
Under a Creative Commons license
open access
Graphical Abstract
Keywords
CRISPR/Cas9
genome editing
drug inducible
stem cells
Cited by (0)
- 5
These authors contributed equally to this work.
- 6
Present address: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- 7
Present address: School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
© 2018 The Authors.